Erythropoietin reduces neuronal cell death and hyperalgesia induced by peripheral inflammatory pain in neonatal rats

Molecular Pain

Volumn 7, Issue , 2011, Pages

  Mohamad, Osama ^a   Chen, Dongdong ^a   Zhang, Lingling ^b   Hofmann, Cane ^b   Wei, Ling ^a,b   Yu, Shan Ping ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cell death; Cerebral blood flow; Erythropoietin; Inflammatory; Neonates; Pain

Indexed keywords

RECOMBINANT ERYTHROPOIETIN; AUTACOID; CYTOKINE; ERYTHROPOIETIN; FORMALDEHYDE; NEUROPROTECTIVE AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN NERVE CELL; BRAIN WEIGHT; CELL DEATH; CONTROLLED STUDY; DRUG RESPONSE; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; HYPERALGESIA; HYPOTHALAMUS; INFLAMMATION; NEWBORN; NOCICEPTION; NONHUMAN; PAIN; PAW EDEMA; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; SOMATOSENSORY CORTEX; ANIMAL; BRAIN; BRAIN CIRCULATION; DISEASE MODEL; DRUG EFFECT; HUMAN; METABOLISM; NERVE CELL; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; VASCULARIZATION;

ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN; CELL DEATH; CEREBROVASCULAR CIRCULATION; CYTOKINES; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; EXPLORATORY BEHAVIOR; FORMALDEHYDE; HUMANS; HYPERALGESIA; INFLAMMATION; INFLAMMATION MEDIATORS; NEURONS; NEUROPROTECTIVE AGENTS; ORGAN SIZE; PAIN; RATS;

EID: 79960556581     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-7-51     Document Type: Article

References (66)

1. Zhuo M, Gebhart GF. Effects of neonatal capsaicin treatment on descending modulation of spinal nociception from the rostral, medial medulla in adult rat. Brain Res 1994, 645(1-2):164-178. 10.1016/0006-8993(94)91650-0, 8062079.
2. Mitchell A, Boss BJ. Adverse effects of pain on the nervous systems of newborns and young children: a review of the literature. J Neurosci Nurs 2002, 34(5):228-236. 10.1097/01376517-200210000-00002, 12391738.
3. Stevens B, Grunau RE. Pain in vulnerable infants Introduction. Clin Perinatol 2002, 29(3):xv-xvii. 10.1016/S0095-5108(02)00023-4, 12380462.
4. Anand KJ, Garg S, Rovnaghi CR, Narsinghani U, Bhutta AT, Hall RW. Ketamine reduces the cell death following inflammatory pain in newborn rat brain. Pediatr Res 2007, 62(3):283-290. 10.1203/PDR.0b013e3180986d2f, 17551412.
5. Guyer B, Strobino DM, Ventura SJ, MacDorman M, Martin JA. Annual summary of vital statistics--1995. Pediatrics 1996, 98(6 Pt 1):1007-1019.
6. Yeaney NK, Murdoch EM, Lees CC. The extremely premature neonate: anticipating and managing care. BMJ 2009, 338:b2325. 10.1136/bmj.b2325, 19546135.
7. Whitfield MF, Grunau RE. Behavior, pain perception, and the extremely low-birth weight survivor. Clin Perinatol 2000, 27(2):363-379. 10.1016/S0095-5108(05)70026-9, 10863655.
8. Fitzgerald M, Beggs S. The neurobiology of pain: developmental aspects. Neuroscientist 2001, 7(3):246-257. 10.1177/107385840100700309, 11499403.
9. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999, 283(5398):70-74. 10.1126/science.283.5398.70, 9872743.
10. Taddio A, Stevens B, Craig K, Rastogi P, Ben-David S, Shennan A, Mulligan P, Koren G. Efficacy and safety of lidocaine-prilocaine cream for pain during circumcision. N Engl J Med 1997, 336(17):1197-1201. 10.1056/NEJM199704243361701, 9110906.
11. Shah V. Alleviation of the pain of venepuncture in neonates. Acta Paediatr 1999, 88(3):351-352.
12. Stevens B, Johnston C, Taddio A, Jack A, Narciso J, Stremler R, Koren G, Aranda J. Management of pain from heel lance with lidocaine-prilocaine (EMLA) cream: is it safe and efficacious in preterm infants?. J Dev Behav Pediatr 1999, 20(4):216-221. 10.1097/00004703-199908000-00003, 10475595.
13. Nandi R, Fitzgerald M. Opioid analgesia in the newborn. Eur J Pain 2005, 9(2):105-108. 10.1016/j.ejpain.2004.05.005, 15737795.
14. Stevens B, Taddio A, Ohlsson A, Einarson T. The efficacy of sucrose for relieving procedural pain in neonates--a systematic review and meta-analysis. Acta Paediatr 1997, 86(8):837-842.
15. Johnston CC, Stevens B, Pinelli J, Gibbins S, Filion F, Jack A, Steele S, Boyer K, Veilleux A. Kangaroo care is effective in diminishing pain response in preterm neonates. Arch Pediatr Adolesc Med 2003, 157(11):1084-1088. 10.1001/archpedi.157.11.1084, 14609899.
16. Huang CM, Tung WS, Kuo LL, Ying-Ju C. Comparison of pain responses of premature infants to the heelstick between containment and swaddling. J Nurs Res 2004, 12(1):31-40. 10.1097/01.JNR.0000387486.78685.c5, 15136961.
17. Johnston CC, Filion F, Nuyt AM. Recorded maternal voice for preterm neonates undergoing heel lance. Adv Neonatal Care 2007, 7(5):258-266.
18. Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood) 2003, 228(1):1-14.
19. Roger SD, Macdougall IC, Thuraisingham RC, Raine AE. Erythropoietin in anemia of renal failure in sickle cell disease. N Engl J Med 1991, 325(16):1175-1176.
20. Henry DH. Recombinant human erythropoietin treatment of anemic cancer patients. Cancer Pract 1996, 4(4):180-184.
21. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000, 97(19):10526-10531. 27058, 10984541.
22. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, Petit E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 1999, 19(6):643-651.
23. Li Y, Lu Z, Keogh CL, Yu SP, Wei L. Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J Cereb Blood Flow Metab 2007, 27(5):1043-1054.
24. Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, Viviani B, Marinovich M, Cerami A, Coleman TR, Brines M, Ghezzi P. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 2003, 198(6):971-975. 10.1084/jem.20021067, 2194205, 12975460.
25. Wang L, Zhang Z, Wang Y, Zhang R, Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004, 35(7):1732-1737. 10.1161/01.STR.0000132196.49028.a4, 15178821.
26. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Ruther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Siren AL. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002, 8(8):495-505. 2040012, 12435860.
27. Campana WM, Li X, Shubayev VI, Angert M, Cai K, Myers RR. Erythropoietin reduces Schwann cell TNF-alpha, Wallerian degeneration and pain-related behaviors after peripheral nerve injury. Eur J Neurosci 2006, 23(3):617-626. 10.1111/j.1460-9568.2006.04606.x, 16487143.
28. Peeters HR, Jongen-Lavrencic M, Vreugdenhil G, Swaak AJ. Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial. Ann Rheum Dis 1996, 55(10):739-744. 10.1136/ard.55.10.739, 1010292, 8984939.
29. Schmued LC, Stowers CC, Scallet AC, Xu L. Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res 2005, 1035(1):24-31. 10.1016/j.brainres.2004.11.054, 15713273.
30. Schmitz C, Hof PR. Design-based stereology in neuroscience. Neuroscience 2005, 130(4):813-831. 10.1016/j.neuroscience.2004.08.050, 15652981.
31. Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977, 4(2):161-174.
32. Hunskaar S, Fasmer OB, Hole K. Formalin test in mice, a useful technique for evaluating mild analgesics. J Neurosci Methods 1985, 14(1):69-76. 10.1016/0165-0270(85)90116-5, 4033190.
33. Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev 1979, 3(1):79-83. 10.1016/0378-3782(79)90022-7, 118862.
34. Andrews K, Fitzgerald M. Biological barriers to paediatric pain management. Clin J Pain 1997, 13(2):138-143. 10.1097/00002508-199706000-00007, 9186020.
35. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 1995, 21(5):1465-1468.
36. Yasuda M, Umemura S, Osamura RY, Kenjo T, Tsutsumi Y. Apoptotic cells in the human endometrium and placental villi: pitfalls in applying the TUNEL method. Arch Histol Cytol 1995, 58(2):185-190. 10.1679/aohc.58.185, 7576870.
37. McDonald JW, Behrens MI, Chung C, Bhattacharyya T, Choi DW. Susceptibility to apoptosis is enhanced in immature cortical neurons. Brain Res 1997, 759(2):228-232. 10.1016/S0006-8993(97)00248-5, 9221941.
38. Cande C, Vahsen N, Garrido C, Kroemer G. Apoptosis-inducing factor (AIF): caspase-independent after all. Cell Death Differ 2004, 11(6):591-595.
39. Grunau R. Early pain in preterm infants A model of long-term effects. Clin Perinatol 2002, 29(3):373-394. vii-viii, 10.1016/S0095-5108(02)00012-X, 12380464.
40. Jia HBJY, Ji Q, Hu YF, Zhou ZQ, Xu JG, Yang JJ. Effects of recombinant human erythropoietin on neuropathic pain and cerebral expressions of cytokines and nuclear factor-kappa B. Can J Anaesth 2009, 58(8):597-603.
41. Simons SH, van Dijk M, Anand KS, Roofthooft D, van Lingen RA, Tibboel D. Do we still hurt newborn babies? A prospective study of procedural pain and analgesia in neonates. Arch Pediatr Adolesc Med 2003, 157(11):1058-1064. 10.1001/archpedi.157.11.1058, 14609893.
42. Taddio A, Katz J, Ilersich AL, Koren G. Effect of neonatal circumcision on pain response during subsequent routine vaccination. Lancet 1997, 349(9052):599-603. 10.1016/S0140-6736(96)10316-0, 9057731.
43. Taddio A, Shah V, Gilbert-MacLeod C, Katz J. Conditioning and hyperalgesia in newborns exposed to repeated heel lances. JAMA 2002, 288(7):857-861. 10.1001/jama.288.7.857, 12186603.
44. Shields SD, Cavanaugh DJ, Lee H, Anderson DJ, Basbaum AI. Pain behavior in the formalin test persists after ablation of the great majority of C-fiber nociceptors. Pain 2010, 151(2):422-429. 10.1016/j.pain.2010.08.001, 20832171.
45. Hassanzadeh P, Ahmadiani A. Nitric oxide and c-Jun N-terminal kinase are involved in the development of dark neurons induced by inflammatory pain. Synapse 2006, 59(2):101-106. 10.1002/syn.20219, 16284960.
46. Negrigo A, Medeiros M, Guinsburg R, Covolan L. Long-term gender behavioral vulnerability after nociceptive neonatal formalin stimulation in rats. Neurosci Lett 2011, 490(3):196-199. 10.1016/j.neulet.2010.12.050, 21194555.
47. Neubauer AP, Voss W, Wachtendorf M, Jungmann T. Erythropoietin improves neurodevelopmental outcome of extremely preterm infants. Ann Neurol 151(2):422-429.
48. Bierer R, Peceny MC, Hartenberger CH, Ohls RK. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 2006, 118(3):e635-640. 10.1542/peds.2005-3186, 16908620.
49. Brown MS, Eichorst D, Lala-Black B, Gonzalez R. Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants. Pediatrics 2009, 124(4):e681-687. 10.1542/peds.2008-2701, 19786428.
50. Ohls RK, Ehrenkranz RA, Das A, Dusick AM, Yolton K, Romano E, Delaney-Black V, Papile LA, Simon NP, Steichen JJ, Lee KG. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics 2004, 114(5):1287-1291. 10.1542/peds.2003-1129-L, 15520109.
51. Garcia MG, Hutson AD, Christensen RD. Effect of recombinant erythropoietin on "late" transfusions in the neonatal intensive care unit: a meta-analysis. J Perinatol 2002, 22(2):108-111. 10.1038/sj.jp.7210677, 11896514.
52. McPherson RJ, Juul SE. Recent trends in erythropoietin-mediated neuroprotection. Int J Dev Neurosci 2008, 26(1):103-111. 10.1016/j.ijdevneu.2007.08.012, 2312376, 17936539.
53. Shields SD, Cavanaugh DJ, Lee H, Anderson DJ, Basbaum AI. Pain behavior in the formalin test persists after ablation of the great majority of C-fiber nociceptors. Pain 1111, 151(2):422-429.
54. Statler PA, McPherson RJ, Bauer LA, Kellert BA, Juul SE. Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatr Res 2007, 61(6):671-675.
55. Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, Keenan S, Gleiter C, Pasquali C, Capobianco A, Mennini T, Heumann R, Cerami A, Ehrenreich H, Ghezzi P. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 2001, 98(7):4044-4049. 10.1073/pnas.051606598, 31176, 11259643.
56. Kilic E, Kilic U, Soliz J, Bassetti CL, Gassmann M, Hermann DM. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J 2005, 19(14):2026-2028.
57. Tsai PT, Ohab JJ, Kertesz N, Groszer M, Matter C, Gao J, Liu X, Wu H, Carmichael ST. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci 2006, 26(4):1269-1274. 10.1523/JNEUROSCI.4480-05.2006, 16436614.
58. Yu X, Shacka JJ, Eells JB, Suarez-Quian C, Przygodzki RM, Beleslin-Cokic B, Lin CS, Nikodem VM, Hempstead B, Flanders KC, Costantini F, Noguchi CT. Erythropoietin receptor signalling is required for normal brain development. Development 2002, 129(2):505-516.
59. Kretz A, Happold CJ, Marticke JK, Isenmann S. Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation. Mol Cell Neurosci 2005, 29(4):569-579. 10.1016/j.mcn.2005.04.009, 15936213.
60. Sun Y, Calvert JW, Zhang JH. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 2005, 36(8):1672-1678. 10.1161/01.STR.0000173406.04891.8c, 16040592.
61. Figiel I. Pro-inflammatory cytokine TNF-alpha as a neuroprotective agent in the brain. Acta Neurobiol Exp (Wars) 2008, 68(4):526-534.
62. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998, 101(2):311-320. 10.1172/JCI1368, 508569, 9435302.
63. Xiao HS, Huang QH, Zhang FX, Bao L, Lu YJ, Guo C, Yang L, Huang WJ, Fu G, Xu SH, Cheng XP, Yan Q, Zhu ZD, Zhang X, Chen Z, Han ZG. Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc Natl Acad Sci USA 2002, 99(12):8360-8365. 10.1073/pnas.122231899, 123072, 12060780.
64. Toth C, Martinez JA, Liu WQ, Diggle J, Guo GF, Ramji N, Mi R, Hoke A, Zochodne DW. Local erythropoietin signaling enhances regeneration in peripheral axons. Neuroscience 2008, 154(2):767-783. 10.1016/j.neuroscience.2008.03.052, 18456410.
65. Durham PL, Russo AF. Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J Neurosci 2003, 23(3):807-815.
66. Adamcio B, Sargin D, Stradomska A, Medrihan L, Gertler C, Theis F, Zhang M, Muller M, Hassouna I, Hannke K, Sperling S, Radyushkin K, El-Kordi A, Schulze L, Ronnenberg A, Wolf F, Brose N, Rhee JS, Zhang W, Ehrenreich H. Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biol 2008, 6:37. 10.1186/1741-7007-6-37, 2562991, 18782446.